Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is T  [Clear All Filters]
Zolfaghari MAli, Arefnezhad R, Parhizkar F, Hejazi MSaeid, Khiavi FMotavalli, Mahmoodpoor A, Yousefi M. T lymphocytes and Preeclampsia: The Potential Role of T cell Subsets and Related MicroRNAs in the Pathogenesis of Preeclampsia. Am J Reprod Immunol. 2021:e13475.
Ramos DM, Skarnes WC, Singleton AB, Cookson MR, Ward ME. Tackling neurodegenerative diseases with genomic engineering: A new stem cell initiative from the NIH. Neuron. 2021;109(7):1080-1083.
Schoepf AM, Salcher S, Obexer P, Gust R. Tackling resistance in chronic myeloid leukemia: Novel cell death modulators with improved efficacy. Eur J Med Chem. 2021;216:113285.
Tsuji-Tamura K, Morino-Koga S, Suzuki S, Ogawa M. TAGLN, a canonical marker of smooth muscle cells, is present in endothelial cells and involved in angiogenesis. J Cell Sci. 2021.
Pathan N, Shende P. Tailoring of P-glycoprotein for effective transportation of actives across blood-brain-barrier. J Control Release. 2021.
Jahnel SM, Mendjan S. Taking Heart Development to the Next Level. Cell Stem Cell. 2021;28(2):180-181.
Zeng B, Zhou M, Liu B, Shen F, Xiao R, Su J, Hu Z, Zhang Y, Gu A, Wu L, et al. Targeted addition of mini-dystrophin into rDNA locus of Duchenne muscular dystrophy patient-derived iPSCs. Biochem Biophys Res Commun. 2021;545:40-45.
Li H, Jin Y, Zhao Y, Li W, He Z, Zhang Q, Huang H, Lin J, Chen Y, Xing D, et al. Targeted cell therapy for partial-thickness cartilage defects using membrane modified mesenchymal stem cells by transglutaminase 2. Biomaterials. 2021;275:120994.
Samarasinghe KTG, Jaime-Figueroa S, Burgess M, Nalawansha DA, Dai K, Hu Z, Bebenek A, Holley SA, Crews CM. Targeted degradation of transcription factors by TRAFTACs: TRAnscription Factor TArgeting Chimeras. Cell Chem Biol. 2021.
Duan Z. Targeted DNase Hi-C. Methods Mol Biol. 2021;2157:65-83.
Sucha R, Kubickova M, Cervenka J, Hruska-Plochan M, Bohaciakova D, Kepkova KVodickova, Novakova T, Budkova K, Susor A, Marsala M, et al. Targeted mass spectrometry for monitoring of neural differentiation. Biol Open. 2021.
Long Y, Cech TR. Targeted mutagenesis in human iPSCs using CRISPR genome-editing tools. Methods. 2021.
Pradhan A, Mishra S, Basu SMercy, Surolia A, Giri J, Srivastava R, Panda D. Targeted nanoformulation of C1 inhibits the growth of KB spheroids and cancer stem cell-enriched MCF-7 mammospheres. Colloids Surf B Biointerfaces. 2021;202:111702.
Vaidyanathan S, Baik R, Chen L, Bravo DT, Suarez CJ, Abazari SM, Salahudeen AA, Dudek AM, Teran CA, Davis TH, et al. Targeted replacement of full-length CFTR in human airway stem cells by CRISPR/Cas9 for pan-mutation correction in the endogenous locus. Mol Ther. 2021.
Akinduro OO, Suarez-Meade P, Garcia D, Brown DA, Sarabia-Estrada R, Attia S, Gokaslan ZL, Quiñones-Hinojosa A. Targeted Therapy for Chordoma: Key Molecular Signaling Pathways and the Role of Multimodal Therapy. Target Oncol. 2021.
Ptasinski V, Stegmayr J, Belvisi MG, Wagner DE, Murray LA. Targeting Alveolar Repair in Idiopathic Pulmonary Fibrosis. Am J Respir Cell Mol Biol. 2021.
Chu M, Zheng C, Chen C, Song G, Hu X, Wang Z-W. Targeting cancer stem cells by nutraceuticals for cancer therapy. Semin Cancer Biol. 2021.
Li X, Chen M, Lu W, Tang J, Deng L, Wen Q, Huang M, Deng R, Ye G, Ye W, et al. Targeting FAPα-expressing tumor-associated mesenchymal stromal cells inhibits triple-negative breast cancer pulmonary metastasis. Cancer Lett. 2021.
Hu Q, Hu X, Zhang L, Zhao Y, Li L. Targeting Hedgehog signalling in CD133-positive hepatocellular carcinoma: improving Lenvatinib therapeutic efficiency. Med Oncol. 2021;38(4):41.
Niu L-T, Wang Y-Q, Wong CCL, Gao S-X, Mo X-D, Huang X-J. Targeting IFN-γ-inducible lysosomal thiol reductase overcomes chemoresistance in AML through regulating the ROS-mediated mitochondrial damage. Transl Oncol. 2021;14(9):101159.
Zhang W, Liu W, Jia L, Chen D, Chang I, Lake M, Bentolila LA, Wang C-Y. Targeting KDM4A epigenetically activates tumor-cell-intrinsic immunity by inducing DNA replication stress. Mol Cell. 2021.
Wosczyna MN, Carbajal EEPerez, Wagner MW, Paredes S, Konishi CT, Liu L, Wang TT, Walsh RA, Gan Q, Morrissey CS, et al. Targeting microRNA-mediated gene repression limits adipogenic conversion of skeletal muscle mesenchymal stromal cells. Cell Stem Cell. 2021.
Yang S, Yang S, Zhang H, Hua H, Kong Q, Wang J, Jiang Y. Targeting Na /K -ATPase by berbamine and ouabain synergizes with sorafenib to inhibit hepatocellular carcinoma. Br J Pharmacol. 2021.
Vundavilli H, Datta A, Sima C, Hua J, Lopes R, Bittner M. Targeting oncogenic mutations in colorectal cancer using cryptotanshinone. PLoS One. 2021;16(2):e0247190.
Li X, Li B, Shi Y, Wang C, Ye L. Targeting reactive oxygen species in stem cells for bone therapy. Drug Discov Today. 2021.